These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30460486)

  • 1. A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications in Egypt.
    Farid S; Elmahdawy M; Baines D
    Clin Drug Investig; 2019 Feb; 39(2):157-168. PubMed ID: 30460486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications for China.
    Jiang S; Ma X; Desai P; Yang L; Rascati K
    Value Health Reg Issues; 2014 May; 3():79-86. PubMed ID: 29702942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the quality of pharmacoeconomic studies in India: a systematic review.
    Desai PR; Chandwani HS; Rascati KL
    Pharmacoeconomics; 2012 Sep; 30(9):749-62. PubMed ID: 22720697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Quality of Pharmacoeconomic Studies in Asia-Pacific Region and Identification of Influencing Variables.
    Pandey P; Pandey RD; Shah V
    Value Health Reg Issues; 2018 May; 15():70-75. PubMed ID: 29474182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The state of health economic research in South Africa: a systematic review.
    Gavaza P; Rascati KL; Oladapo AO; Khoza S
    Pharmacoeconomics; 2012 Oct; 30(10):925-40. PubMed ID: 22809450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review and Quality Assessment of Health Economic Evaluation Studies (2007-2019) Conducted in South Korea.
    Yi S; Hong J; Yoon H; Lim YN; Bae EY
    Appl Health Econ Health Policy; 2022 Nov; 20(6):819-834. PubMed ID: 35869356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHARMACOECONOMIC STUDIES IN WORLD HEALTH ORGANIZATION EASTERN MEDITERRANEAN COUNTRIES: REPORTING COMPLETENESS.
    Alefan Q; Rascati K
    Int J Technol Assess Health Care; 2017 Jan; 33(2):215-221. PubMed ID: 28578712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Pharmacoeconomic Studies in Russian Cancer Research: An Outside View.
    Djalalov S; Djalalova D; Krahn M; Matveev N; Hoch JS
    Value Health Reg Issues; 2019 Sep; 19():138-144. PubMed ID: 31472421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analyses of breast cancer medications use in developing countries: a systematic review.
    Al-Ziftawi NH; Shafie AA; Mohamed Ibrahim MI
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):655-666. PubMed ID: 32657174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review of Methods and Study Quality of Economic Evaluations for the Treatment of Schizophrenia.
    Wang L; Shi F; Guan X; Xu H; Liu J; Li H
    Front Public Health; 2021; 9():689123. PubMed ID: 34746073
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt.
    Elsisi GH; Kaló Z; Eldessouki R; Elmahdawy MD; Saad A; Ragab S; Elshalakani AM; Abaza S
    Value Health Reg Issues; 2013; 2(2):319-327. PubMed ID: 29702884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the value and quality of health economic analyses: implications of utilizing the QHES.
    Ofman JJ; Sullivan SD; Neumann PJ; Chiou CF; Henning JM; Wade SW; Hay JW
    J Manag Care Pharm; 2003; 9(1):53-61. PubMed ID: 14613362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Quality of Economic Evaluations of FDA Novel Drug Approvals: A Systematic Review.
    Woersching AL; Borrego ME; Raisch DW
    Ann Pharmacother; 2016 Dec; 50(12):1028-1040. PubMed ID: 27489087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review and Quality Evaluation of Pharmacoeconomic Studies on Traditional Chinese Medicines.
    Yang N; Zhang H; Deng T; Guo JJ; Hu M
    Front Public Health; 2021; 9():706366. PubMed ID: 34414159
    [No Abstract]   [Full Text] [Related]  

  • 15. Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries.
    Alzarea AI; Khan YH; Alanazi AS; Butt MH; Almalki ZS; AlAhmari AK; Alsahali S; Mallhi TH
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomic education in Egyptian schools of pharmacy.
    Soliman AM; Hussein M; Abdulhalim AM
    Am J Pharm Educ; 2013 Apr; 77(3):57. PubMed ID: 23610475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of pharmacoeconomic research in China: A systematic review.
    Ma H; Jian W; Xu T; He Y; Rizzo JA; Fang H
    Medicine (Baltimore); 2016 Oct; 95(41):e5114. PubMed ID: 27741131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].
    Hoomans T; van der Roer N; Severens JL; Delwel GO
    Ned Tijdschr Geneeskd; 2010; 154():A958. PubMed ID: 20699045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review.
    Mori AT; Robberstad B
    BMC Med Inform Decis Mak; 2012 Sep; 12():110. PubMed ID: 23016739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics.
    Min C; Xue M; Haotian F; Jialian L; Lingli Z
    PLoS One; 2021; 16(2):e0246080. PubMed ID: 33556056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.